Repro Med Systems with ticker code (KRMD) have now 4 analysts in total covering the stock. The consensus rating is ‘Buy’. The target price ranges between 16 and 9 and has a mean target at 11.25. Now with the previous closing price of 6.22 this is indicating there is a potential upside of 80.9%. The 50 day MA is 4.93 while the 200 day moving average is 7.6. The company has a market capitalisation of $278m. Find out more information at: http://www.korumedical.com
The potential market cap would be $502m based on the market concensus.
Repro Med Systems, doing business as KORU Medical Systems, designs, manufactures, and markets portable medical devices primarily for the ambulatory infusion market in the United States and internationally. The company offers mechanical infusion product comprising the FREEDOM infusion systems that include the FREEDOM60 syringe driver, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing. It also provides education and training materials to clinicians, patients, and patient advocates. The company sells its products through direct sales and medical device distributors, as well as online. Repro Med Systems was founded in 1980 and is headquartered in Chester, New York.
